InsidersTradesSigma
Explore the full management transaction log of Biomark Diagnostics Inc., a publicly traded company based in Canada. Shares are listed on CA CA, under the oversight of SEDI. Operating in the Health Care sector, Biomark Diagnostics Inc. has recorded 4 public disclosures. Market capitalisation: €36.2m. The latest transaction was reported on 29 May 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Maula Bux, Rashid Ahmed. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
4 of 4 declarations